NATURE’S SUNSHINE PRODUCTS, INC. Current Assets
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Current Assets of $178.40 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-06
- 2026-06-30: Assets, Current $178.40M.
- 2026-03-31: Assets, Current $178.59M.
- 2025-12-31: Assets, Current $178.84M.
- 2025-09-30: Assets, Current $186.08M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $178.40M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $178.59M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $178.84M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $186.08M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $171.84M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $170.78M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $160.58M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $163.53M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $152.04M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $160.16M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $165.82M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $160.22M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $155.91M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $154.42M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $149.51M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $142.80M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $147.15M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $148.64M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $164.67M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $150.73M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $143.69M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $154.80M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $154.06M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $144.98M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $134.07M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $120.23M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $112.70M 10-K · filed 2021-03-10 | |
| 2019-09-30 | $108.52M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $105.59M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $103.30M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $106.83M 10-K · filed 2020-03-11 | |
| 2018-09-30 | $104.98M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $104.40M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $100.91M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $102.51M 10-K · filed 2019-03-08 | |
| 2017-09-30 | $114.31M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $97.90M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $97.72M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $94.50M 10-K · filed 2018-03-16 | $100.12M 10-K · filed 2017-03-14 |
| 2016-09-30 | $110.20M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $109.03M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $110.00M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $101.52M 10-K · filed 2017-03-14 | |
| 2015-09-30 | $104.76M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $112.35M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $117.20M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $121.25M 10-K · filed 2016-03-14 | |
| 2014-09-30 | $139.54M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $139.44M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $145.11M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $148.59M 10-K · filed 2015-03-13 | |
| 2013-09-30 | $145.40M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $151.70M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $148.06M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $145.33M 10-K · filed 2014-03-17 | |
| 2012-09-30 | $139.01M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $131.61M 10-Q · filed 2012-08-03 | |
| 2012-03-31 | $128.18M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $125.10M 10-K · filed 2013-03-07 | |
| 2011-09-30 | $118.90M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $127.37M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $106.54M 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |